V66I (p.Val66Ile) variant of PTH (Parathyroid hormone)

V66I (p.Val66Ile) in PTH (Parathyroid hormone) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.19 / 1. The record also includes population frequency data and structural context.

V66I (p.Val66Ile) variant details